KR20060008662A - Hair growth promoter composition - Google Patents
Hair growth promoter composition Download PDFInfo
- Publication number
- KR20060008662A KR20060008662A KR1020040057508A KR20040057508A KR20060008662A KR 20060008662 A KR20060008662 A KR 20060008662A KR 1020040057508 A KR1020040057508 A KR 1020040057508A KR 20040057508 A KR20040057508 A KR 20040057508A KR 20060008662 A KR20060008662 A KR 20060008662A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- hair
- composition
- hair growth
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000003779 hair growth Effects 0.000 title claims abstract description 55
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 239000007952 growth promoter Substances 0.000 title claims abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 112
- 230000000694 effects Effects 0.000 claims abstract description 73
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 claims abstract description 29
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 26
- 230000003658 preventing hair loss Effects 0.000 claims abstract description 24
- 239000004480 active ingredient Substances 0.000 claims abstract description 10
- 240000004638 Dendrobium nobile Species 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 239000004615 ingredient Substances 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 10
- 210000004761 scalp Anatomy 0.000 claims description 8
- 244000223014 Syzygium aromaticum Species 0.000 claims description 6
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 241000283690 Bos taurus Species 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- 244000170916 Paeonia officinalis Species 0.000 claims description 4
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 150000002430 hydrocarbons Chemical class 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 2
- 244000299790 Rheum rhabarbarum Species 0.000 claims description 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 240000002657 Thymus vulgaris Species 0.000 claims description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 2
- 229940072117 fennel extract Drugs 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000001585 thymus vulgaris Substances 0.000 claims description 2
- 239000012049 topical pharmaceutical composition Substances 0.000 claims description 2
- 239000008513 turmeric extract Substances 0.000 claims description 2
- 229940052016 turmeric extract Drugs 0.000 claims description 2
- 235000020240 turmeric extract Nutrition 0.000 claims description 2
- 244000080767 Areca catechu Species 0.000 claims 1
- 235000006226 Areca catechu Nutrition 0.000 claims 1
- 240000007124 Brassica oleracea Species 0.000 claims 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims 1
- 235000002789 Panax ginseng Nutrition 0.000 claims 1
- 240000003307 Zinnia violacea Species 0.000 claims 1
- 210000000232 gallbladder Anatomy 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 47
- 201000004384 Alopecia Diseases 0.000 abstract description 36
- 230000003676 hair loss Effects 0.000 abstract description 23
- 208000024963 hair loss Diseases 0.000 abstract description 23
- 210000004209 hair Anatomy 0.000 abstract description 21
- 230000006698 induction Effects 0.000 abstract description 20
- 230000003698 anagen phase Effects 0.000 abstract description 19
- 210000003780 hair follicle Anatomy 0.000 abstract description 13
- 210000000442 hair follicle cell Anatomy 0.000 abstract description 11
- 239000004575 stone Substances 0.000 abstract description 9
- 230000031774 hair cycle Effects 0.000 abstract description 5
- 230000016507 interphase Effects 0.000 abstract description 4
- 230000007704 transition Effects 0.000 abstract description 3
- 238000004904 shortening Methods 0.000 abstract description 2
- 230000009471 action Effects 0.000 description 18
- 238000011156 evaluation Methods 0.000 description 13
- 230000006872 improvement Effects 0.000 description 12
- 231100000360 alopecia Toxicity 0.000 description 11
- 230000007246 mechanism Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 235000020710 ginseng extract Nutrition 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 6
- 239000012091 fetal bovine serum Substances 0.000 description 6
- 229940088597 hormone Drugs 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical group C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 208000001840 Dandruff Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000003098 androgen Substances 0.000 description 3
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 3
- 230000020411 cell activation Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 229940104230 thymidine Drugs 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 210000002268 wool Anatomy 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- 238000011740 C57BL/6 mouse Methods 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 235000007862 Capsicum baccatum Nutrition 0.000 description 2
- 241001076416 Dendrobium tosaense Species 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- 201000002996 androgenic alopecia Diseases 0.000 description 2
- 229960003473 androstanolone Drugs 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- 239000001728 capsicum frutescens Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical group C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- WKNQKPAPFFKRBJ-DPMUJHKHSA-N 6-Hydroxydendroxine Natural products O=C1O[C@@H]2[C@@H](C(C)C)[C@H]1[C@@]1(O)[C@]3(C)[C@@H](CN4[C@]23OCC4)CC1 WKNQKPAPFFKRBJ-DPMUJHKHSA-N 0.000 description 1
- WKNQKPAPFFKRBJ-UHFFFAOYSA-N 6-Oxy-dendroxin Natural products CC12C3(O)CCC2CN2CCOC12C1C(C(C)C)C3C(=O)O1 WKNQKPAPFFKRBJ-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- CCEAFOJVRQZWQC-UHFFFAOYSA-N Ddendroxine Natural products CC12C3CCC2CN2CCOC12C1C(C(C)C)C3C(=O)O1 CCEAFOJVRQZWQC-UHFFFAOYSA-N 0.000 description 1
- QSNCUGULHPBRGR-UHFFFAOYSA-N Dendramine Natural products CC12C3(O)CCC2CN(C)C1C1C(C(C)C)C3C(=O)O1 QSNCUGULHPBRGR-UHFFFAOYSA-N 0.000 description 1
- 102100030312 Dendrin Human genes 0.000 description 1
- RYAHJFGVOCZDEI-UFFNCVEVSA-N Dendrobine Chemical compound C([C@H]1CC[C@@H]2[C@@]31C)N(C)[C@@H]3[C@H]1[C@@H](C(C)C)[C@@H]2C(=O)O1 RYAHJFGVOCZDEI-UFFNCVEVSA-N 0.000 description 1
- 241000026010 Dendrobium candidum Species 0.000 description 1
- 241001076417 Dendrobium linawianum Species 0.000 description 1
- CCEAFOJVRQZWQC-KFYGABLUSA-N Dendroxine Natural products O=C1O[C@@H]2[C@@H](C(C)C)[C@@H]1[C@H]1[C@]3(C)[C@@H](CN4[C@]23OCC4)CC1 CCEAFOJVRQZWQC-KFYGABLUSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- MAEQVSBPCIMMJF-UHFFFAOYSA-N Nobilonin Natural products CC(C)C1C2C(=O)C3(C)C(CN(C)C)CCC3C1C(=O)O2 MAEQVSBPCIMMJF-UHFFFAOYSA-N 0.000 description 1
- MAEQVSBPCIMMJF-MSZYXCAISA-N Nobilonine Natural products O=C1[C@@]2(C)[C@@H](CN(C)C)CC[C@H]2[C@H]2[C@H](C(C)C)[C@H]1OC2=O MAEQVSBPCIMMJF-MSZYXCAISA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 240000008154 Piper betle Species 0.000 description 1
- 235000008180 Piper betle Nutrition 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 230000003778 catagen phase Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 108010014851 dendrin Proteins 0.000 description 1
- RYAHJFGVOCZDEI-CZKZLRAZSA-N dendrobine Natural products O=C1O[C@@H]2[C@H](C(C)C)[C@H]1[C@H]1[C@@]3(C)[C@@H]2N(C)C[C@H]3CC1 RYAHJFGVOCZDEI-CZKZLRAZSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000013210 evaluation model Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000010438 granite Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003662 hair growth rate Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- -1 include hinokithiol Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940052200 mold extract Drugs 0.000 description 1
- 210000002488 outer root sheath cell Anatomy 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000003797 telogen phase Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 석곡(石斛, Dendrobium nobile) 추출물을 함유하는 탈모 방지 및 모발 성장 촉진제 조성물에 관한 것으로, 유효성분으로서 모발의 성장 주기 가운데 휴지기에서 성장기로 이행하는 주기를 단축시켜 새로운 모발이 빨리 자라게 하는 모발 성장기 유도 촉진 작용과 함께 모낭 세포 활성 작용이 우수한 석곡 추출물을 함유하는 본 발명의 조성물은 부작용이 거의 없고 우수한 모발 성장 촉진 및 탈모 방지 효과를 나타내며, 5α-리덕타제 활성 억제 작용이 있는 성분을 동시에 함유하였을 경우에도 매우 안전하며 더욱 우수한 탈모 방지 및 모발 성장 촉진 효과가 있다.The present invention relates to a hair loss prevention and hair growth promoter composition containing a stone extract (石斛, Dendrobium nobile ) extract, as an active ingredient hair shortening the transition period from the resting phase to the growth phase of the hair growth cycle of new hair The composition of the present invention, which contains a grain extract having excellent hair follicle cell activity, together with a growth phase induction promoting action, shows an excellent effect of promoting hair growth and preventing hair loss, and simultaneously contains a component having a 5α-reductase activity inhibiting effect. Even if it is very safe and has excellent hair loss prevention and hair growth promoting effect.
석곡 추출물, 5알파-리덕타제, 모발 성장 촉진, 모낭세포 활성, 탈모 방지.Stone Extract, 5 alpha-reductase, promotes hair growth, hair follicle activity, prevents hair loss.
Description
본 발명은 석곡(石斛, Dendrobium nobile) 추출물을 함유하는 탈모 방지 및 모발 성장 촉진제 조성물에 관한 것으로, 더욱 구체적으로 본 발명은 유효성분으로서 모발의 성장 주기 가운데 휴지기에서 성장기로 이행하는 주기를 단축시켜 새로운 모발이 빨리 자라게 하는 모발 성장기 유도 촉진 효과와 함께 모낭 세포 활성 작용이 우수한 석곡 추출물을 함유하는 모발 성장 촉진제에 관련된다.The present invention relates to a hair loss prevention and hair growth accelerator composition containing Dendrobium nobile extract, more specifically, the present invention as an active ingredient to shorten the cycle of transition from the resting phase to the growth phase of the hair growth cycle as a new active ingredient The present invention relates to a hair growth promoter containing a grain extract having excellent hair follicle cell activation with an effect of promoting hair growth phase inducing hair to grow quickly.
인체의 모발은 약 10만∼15만 개 정도로, 각각의 모발은 서로 다른 주기를 가지며 성장기(anagen), 퇴행기(catagen), 휴지기(telogen)를 거쳐 성장, 탈락한다. 이러한 주기는 3∼6년에 걸쳐 반복되는데, 그 결과 정상적으로 하루 평균 50∼100 개의 모발이 탈락하게 된다. 일반적으로 탈모증이라 함은 이러한 주기 중에서 성장기의 모발 비율이 짧아지고 퇴행기 또는 휴지기의 모발이 많아져 비정상적으로 모발이 탈락하는 숫자가 많아지는 것을 일컫는다.Human hair is about 100,000 to 150,000 pieces, each hair has a different cycle and grow and drop out through the anagen, catagen, telogen. This cycle is repeated over three to six years, resulting in an average of 50 to 100 hairs falling out per day. Generally, the term alopecia refers to the increase in the number of hairs that fall abnormally due to shortening of the hair growth rate in the growth phase and more hair in the degenerative or resting phase.
탈모의 원인으로는 남성호르몬 작용 과잉설, 피지 분비 과잉설, 혈액순환 불량설, 과산화물이나 세균 등에 의한 두피 기능 저하설, 유전적 요인, 노화, 스트레스 등이 논의되어 왔다. 그러나 현재까지 탈모에 관한 명확한 원인은 밝혀져 있지 않은 상태이며, 매우 복잡한 작용이 얽혀 있는 것으로 알려져 있다.The causes of alopecia have been discussed, such as excessive male hormone action, excessive sebum secretion, poor blood circulation, hypoglycemia caused by peroxide or bacteria, genetic factors, aging, stress. However, to date, no clear cause for hair loss is unknown, and it is known that a very complicated action is intertwined.
이처럼 다양하고 복잡한 탈모 원인에 대하여, 현재까지 알려진 탈모 방지 제품에는 유효성분으로 혈행 촉진, 모근 기능 강화, 두피 보습 효과, 비듬 방지 효과, 항산화 효과, 모발성장기 연장 효과, 남성호르몬 작용 억제 등을 목적으로 하는 성분 등이 포함되어 있으나, 효과 면에서 뚜렷한 효과를 지닌 것은 아직까지 없는 상태이고 부작용의 문제가 제기되기도 한다.As for the various causes of hair loss, hair loss prevention products known to date are effective ingredients for promoting blood circulation, strengthening hair root function, moisturizing scalp, preventing dandruff, antioxidant effect, hair growth period, and suppressing male hormone activity. It contains ingredients, etc., but there is still no clear effect in terms of effects and side effects may be raised.
탈모 방지 및 모발 성장 촉진 연구에 이용되는 실험법으로는 실험동물을 이용한 in vivo 평가와 모낭세포 및 조직 배양을 이용한 in vitro 평가 등이 주로 이용되고 있다. 1980년대에 들어 모낭을 구성하고 있는 핵심 세포인 모유두세포 (dermal papilla cell)와 외모근초세포(outer root sheath cell)의 배양법이 개발되면서 모낭에서의 분화기전에 대한 연구가 활기를 띠게 되었으며, 이후 모낭조직 배양법이 개발되면서 발모, 양모 및 탈모 방지 등의 연구에 유용한 평가모델로 활용될 수 있는 가능성을 보여주었다. 최근에는 생화학적, 분자생물학적 실험 방법을 이용하여 모발 성장과 관련된 각종 성장인자나 유전자의 동정, 작용기전 연구 및 약물탐색 연구 역시 활발히 진행되고 있다.Experimental methods used to prevent hair loss and promote hair growth are mainly used in vivo evaluation using experimental animals and in vitro evaluation using hair follicle cells and tissue culture. In the 1980s, research on the differentiation mechanism of hair follicles became active with the development of culture methods of dermal papilla cells and outer root sheath cells, which are the core cells of hair follicles. With the development of tissue culture methods, it has been shown to be a useful evaluation model for research on hair growth, wool and hair loss prevention. In recent years, biochemical and molecular biological experiments have been actively conducted to identify various growth factors and genes related to hair growth, research on mechanism of action, and drug search.
모발 성장 촉진 또는 탈모 방지제로서 시판되는 제품이 모발에 미치는 작용으로는 성장기 유도 효과, 모발 성장기 연장 효과, 5α-리덕타제 저해 효과, 혈행 촉진 효과, 살균 효과, 비듬 방지 효과, 보습 효과, 항산화 효과 등이 있으나, 기존의 제제에서 탈모 방지 및 모발 성장 촉진 효과는 충분하지 않다.The effects of a commercially available product on the hair as a hair growth or hair loss preventing agent on the hair include growth phase induction effect, hair growth phase extension effect, 5α-reductase inhibitory effect, blood circulation promoting effect, bactericidal effect, anti dandruff effect, moisturizing effect, antioxidant effect, etc. However, in the existing formulations, hair loss prevention and hair growth promoting effects are not sufficient.
남성형 탈모증은 남성호르몬 의존적이어서 남성호르몬의 양과 직접적인 관계 가 있으며, 이에 따라 최근 남성호르몬 활성 억제를 통해 탈모를 예방 및 치료하기 위한 많은 연구가 보고되고 있다. 남성호르몬에 대한 탈모의 기전을 간략히 설명하면 다음과 같다. 즉, 남성호르몬 중의 하나인 테스토스테론(testosterone)은 5α-리덕타제라는 효소에 의해 활성형 남성호르몬인 디하이드로테스토스테론 (dihydrotestosterone)으로 전환되고, 이처럼 활성화된 호르몬이 일정한 수용체와 결합하여 탈모를 일으키는 단백질을 유도하게 되어 탈모를 진행시키게 된다. 또한, 이와 같은 기전에 의해 피지를 과잉 생성하기도 하여 여드름이나 지루성 피부염 등을 일으키기도 하는데, 그 결과로서 두피에서는 염증을 동반한 탈모가 나타나기도 한다. 결과적으로 남성형 탈모증은 5α-리덕타제의 작용에 의한 디하이드로테스토스테론의 과잉 생성 때문으로, 5α-리덕타제의 활성을 억제한다면 남성형 탈모증을 근본적이고 효과적으로 예방 및 치료할 수 있을 것이다. 이와 같은 관점에서 남성의 전립선 치료제로 사용되어 오던 피나스테라이드(finasteride)라는 성분을 이용한 남성형 탈모증 치료제가 개발되기도 하였으나 성기능 장애 등의 부작용이 보고된 일도 있을 뿐 아니라, 탈모에 대해서 이들의 5α-리덕타제 활성 억제 작용 단독으로는 그 효과를 충분히 기대하기도 어렵다.Androgenetic alopecia is directly dependent on the amount of androgen, which is dependent on androgen hormones. Accordingly, many studies have recently been reported to prevent and treat hair loss by inhibiting androgen activity. Briefly explain the mechanism of hair loss on male hormones are as follows. In other words, testosterone, one of the male hormones, is converted to dihydrotestosterone, an active male hormone, by an enzyme called 5α-reductase. Induces hair loss. In addition, such mechanisms may cause excessive production of sebum, causing acne, seborrheic dermatitis, and the like, and as a result, scalp may occur with inflammation. As a result, androgenetic alopecia is due to the excessive production of dihydrotestosterone by the action of 5α-reductase, it will be able to prevent and treat masculine alopecia by inhibiting the activity of 5α-reductase. In view of this, male hair loss treatment using finasteride, which has been used as a prostate treatment for men, has been developed, but side effects such as sexual dysfunction have been reported, and their 5α-reductase activity against hair loss It is also difficult to fully anticipate the effect by inhibitory effect alone.
이상과 같은 문제점을 고려하여, 본 발명자들은 여러 메커니즘에 대한 효과 중에서 모발의 성장기 유도 촉진 작용을 확인할 수 있는 동물실험을 통해 수십 종의 식물 추출물을 스크리닝한 결과, 석곡 추출물에서 모발 성장기 유도 촉진 효과가 탁월함을 발견하였으며, 또한 석곡 추출물의 모낭세포 활성 작용을 평가한 실험에서도 매우 우수한 결과를 얻어 본 발명의 완성에 이르게 되었다. In view of the above problems, the present inventors screened dozens of plant extracts through animal experiments to confirm the growth-induction promoting action of hair among the effects on various mechanisms, hair growth period induction promoting effect in the stone extract It was found to be excellent, and also in the experiment evaluating the hair follicle cell activity of the Seokgok extract, very good results were obtained, which led to the completion of the present invention.
구체적으로, 본 발명자들은 탈모증에 대한 탈모 방지 및 모발 성장 촉진의 효과를 갖는 동시에 인체에 대한 안전성도 확보된 식물 추출물 수십 종을 선택하여 모발 성장기 유도 촉진 효과에 대한 연구를 수행한 결과, 석곡 추출물이 새로운 모발이 나고 자라서 다시 빠지게 되는 모발성장 주기 가운데 휴지기에서 성장기로 이행하는 단계를 촉진시킨다는 것을 발견하게 되었다. 더우기, 석곡 추출물은 모낭세포에 대한 활성 작용을 평가하는 in vitro 평가에서도 매우 우수한 결과를 나타내었다.Specifically, the present inventors selected dozens of plant extracts having the effect of preventing hair loss and promoting hair growth for alopecia and securing safety to the human body, and then conducted a study on hair growth induction promoting effect, and the stone extract was In the hair growth cycle where new hair grows, grows and falls out, it is found that it promotes the transition from the resting phase to the growth phase. Moreover, Seokgok extract also showed very good results in vitro evaluation of the activity of hair follicle cells.
이와 같은 석곡 추출물을 모발 제품에 이용한 예로서는 일본특허공개 제2000-154113호가 있는데, 여기에서는 석곡(Dendrobium officinale)을 보습성 식물 추출물로서, 건조하고 거친 피부, 비듬, 가려움, 지모, 절모, 광택 부여 등의 목적에 사용하는 화장품 조성물의 원료가 개시되어 있다. 그러나, 석곡을 모발 성장 촉진이나 탈모 방지와 관련하여 이용한다고 기재되어 있는 특허나 문헌은 없다.An example of using such a grain extract in hair products is Japanese Patent Application Laid-Open No. 2000-154113, where a grain extract ( Dendrobium officinale ) is used as a moisturizing plant extract. The raw material of the cosmetic composition used for the purpose of this is disclosed. However, there are no patents or documents that use grains in connection with promoting hair growth or preventing hair loss.
본 발명의 목적은 부작용이 거의 없고 우수한 모발 성장 촉진 및 탈모 방지 효과를 갖는 모발 성장 촉진제 조성물을 제공하고자 하는 것이다.It is an object of the present invention to provide a hair growth promoter composition which has little side effects and has excellent hair growth promoting and anti-hair loss effects.
상기 목적을 달성하기 위하여, 본 발명에서는 석곡(石斛, Dendrobium nobile) 추출물을 유효성분으로 포함하는 탈모 방지 및 모발 성장 촉진제 조성물을 제공한다.In order to achieve the above object, the present invention provides a hair loss prevention and hair growth promoter composition comprising an extract of Seokgok (石斛, Dendrobium nobile ) as an active ingredient.
여기에서, 석곡 추출물의 함량은 고형분으로서 조성물 전체 중량의 0.01∼10 중량%인 것이 바람직하고, 석곡 추출물의 추출 용매는 저급 알코올 및 탄화수소계 용매 중의 1 종 또는 2 종 이상의 혼합 용매일 수 있다.Here, the content of the grains extract is preferably 0.01 to 10% by weight of the total weight of the composition as a solid content, the extraction solvent of the grains extract may be one or two or more mixed solvents of lower alcohols and hydrocarbon-based solvents.
또한, 본 발명의 조성물은 1 종 이상의 5α-리덕타제 활성 억제 성분을 더욱 포함할 수 있으며, 여기에서 5α-리덕타제 활성 억제 성분의 함량은 0.001∼10 중량%인 것이 바람직하다.In addition, the composition of the present invention may further comprise at least one 5α-reductase activity inhibiting component, wherein the content of the 5α-reductase activity inhibiting component is preferably 0.001 to 10% by weight.
그리고, 본 발명의 조성물은 액제, 크림제, 페이스트, 에어로솔제 등의 두피에 적용시킬 수 있는 경피 국소 도포형 제제에 포함될 수 있다.In addition, the composition of the present invention may be included in a transdermal topical formulation that can be applied to the scalp, such as a liquid, cream, paste, aerosol.
본 발명에 따라 석곡 추출물을 포함하는 조성물은, 석곡 추출물이 모발 성장기 유도 촉진이라는 명확한 작용기전을 가질 뿐 아니라, 모낭세포에 대한 활성 작용이 있어 모발 성장 촉진 효과를 나타낸다. 또한, 석곡 추출물과 함께 유효성분으로서 5α-리덕타제 활성 억제 성분을 더욱 포함할 경우 탈모 방지 및 모발 성장 촉진 효과가 더욱 우수하게 될 수 있다.According to the present invention, the composition comprising the Seokgok extract has a clear mechanism of action that promotes hair growth phase induction, as well as an active action on hair follicle cells, thereby exhibiting hair growth promoting effect. In addition, when the addition of 5α-reductase activity inhibitory ingredient as an active ingredient with the Seokok extract can be more excellent hair loss prevention and hair growth promoting effect.
이하, 본 발명의 조성물에 대하여 보다 구체적으로 설명한다.Hereinafter, the composition of this invention is demonstrated more concretely.
먼저, 본 발명이 이루어진 배경을 살펴보면, 탈모증에 대한 탈모 방지 및 모발 성장 촉진 효과를 위해서는 다양한 탈모 원인 또는 작용기전에 대하여 다각적인 메커니즘을 통해 접근하여야 하며, 각각의 작용기전에 대한 최적의 조성비가 요구됨을 전제로 하여 연구 검토하였다. 우선 인체에 대한 안전성이 확보된 성분들 중에서 남성호르몬 작용 조절 성분, 혈액순환 촉진 성분, 세포 활성 작용 성분, 항염증 성분 등 수백 가지 조합과 이들 조합의 탈모 방지 및 모발 성장 촉진 작용을 스크리닝하였으며, 그 결과, 석곡 추출물이 모발 성장기 유도 촉진 작용과 모낭세포 활성 작용이 우수하다는 것을 발견하였다. 또한, 석곡 추출물과 함께 남성호르몬 작용 조절을 위한 5α-리덕타제 활성 억제 성분을 함께 포함하는 조성물은 매우 우수한 탈모 방지 및 모발 성장 촉진 효과가 있을 뿐 아니라, 부작용도 나타나지 않는다는 것도 발견하게 되었다. 따라서, 본 발명에서는 모발 성장과 탈모 방지에 있어서 중요한 요인으로 평가되는 모발 성장기 유도 촉진 작용, 모낭세포 활성 작용, 5α-리덕타제 활성 억제 작용 등의 관점에서, 여러가지 탈모 원인에 대한 복합적인 작용을 통하여 탈모 방지, 모발 성장 촉진 작용을 갖는 조성물을 제공하게 된다.First, in view of the background of the present invention, in order to prevent hair loss and promote hair growth for alopecia, various hair loss mechanisms or mechanisms of action should be approached through a variety of mechanisms. The study was examined. First of all, we have screened hundreds of combinations of male hormone-regulating components, blood circulation promoting components, cell activating components, and anti-inflammatory components, and hair loss prevention and hair growth promoting effects. As a result, it was found that Seokgok extract has excellent hair growth induction promoting action and hair follicle cell activity. In addition, it was also found that the composition including the 5α-reductase activity inhibitory ingredient for controlling male hormone action together with the grains extract has not only excellent hair loss prevention and hair growth promoting effect, but also no side effects. Therefore, in the present invention, in terms of hair growth stage induction promoting action, hair follicle cell activation action, 5α-reductase activity inhibiting action, and the like, which are evaluated as important factors for hair growth and hair loss prevention, a combination of various causes of hair loss is provided. It is to provide a composition having a hair loss prevention and hair growth promoting action.
본 발명의 조성물에서 석곡은 난초과(Orchidaceae) 식물인 금채석곡(Dendrobium nobile) 또는 기타 동속식물인 장과석곡(Dendrobium linawianum), 철피석곡(Dendrobium officinale), 세경석곡(Dendrobium moniliforme) 등의 지상부를 사용하는 생약으로, 생약명은 덴드로비 헤르바(Dendrobii Herba)이다. 석곡의 성상은 편원주형으로 길이 20∼40 ㎝, 지름 4∼6 ㎜이고 마디의 길이는 25∼30 ㎜이다. 바깥면은 금황색∼황록색을 띠고 깊은 세로홈이 있다. 이 생약은 거의 냄새가 없고 맛은 조금 쓰다. 대표적인 주성분으로는 덴드로빈(dendrobine), 덴드라민(dendramine), 노빌로닌(nobilonine), 덴드록신(dendroxine), 덴드린(dendrin), 6-히드록시덴드록신(6-hydroxydendroxine) 등의 약효성분을 포함하고 있으며, 기타 동속 생약들의 성분이 들어있다.In the composition of the present invention, Seokgok uses ground parts such as Dendrobium nobile (Orchidaceae) or other genus plants Dendrobium linawianum , Dendrobium officinale , Dendrobium moniliforme , etc. The herbal name is Dendrobii Herba . The shape of the granite is oblong, 20-40 cm in length, 4-6 mm in diameter, and the length of the node is 25-30 mm. The outer surface is golden yellow to yellow green with deep vertical grooves. This herb has almost no smell and tastes a bit bitter. Typical active ingredients include dendrobine, dendramine, nobilonine, dendroxine, dendrin, and 6-hydroxydendroxine. It contains, and contains the ingredients of other similar herbal medicines.
본 발명의 조성물에 포함되는 석곡 추출물의 제조방법을 살펴보면, 먼저 석곡의 지상부를 정제하고 세절하여 약 10 배량의 추출 용매에서 5 일간 냉침한 후, 추출 원액을 여과, 농축 및 동결건조 등의 방법을 통해 석곡 추출물의 건조분말을 얻는다. 이때 추출 용매로는 그 선택에 있어서 특별히 한정되지는 않으며 정제수; 메탄올, 에탄올, 이소프로필알코올, n-부탄올 등의 저급 알코올; 글리세롤, 프로필렌글리콜, 1,3-부틸렌글리콜 등의 다가 알코올; 그리고 메틸아세테이트, 에틸아세테이트, 벤젠, n-헥산, 디에틸에테르, 디클로로메탄 등의 탄화수소계 용매 등을 예로 들 수 있다. 이들 용매 중에서도, 저급 알코올 및 탄화수소계 용매 중의 1 종 또는 2 종 이상의 혼합 용매가 바람직하다.Looking at the manufacturing method of the grain extract contained in the composition of the present invention, first, the ground portion of the grain is refined and finely cooled for 5 days in about 10 times the amount of the extraction solvent, and then the extraction extract is filtered, concentrated and lyophilized Through the dry powder of the grains extract is obtained. At this time, the extraction solvent is not particularly limited in the selection, purified water; Lower alcohols such as methanol, ethanol, isopropyl alcohol and n-butanol; Polyhydric alcohols such as glycerol, propylene glycol and 1,3-butylene glycol; And hydrocarbon solvents such as methyl acetate, ethyl acetate, benzene, n-hexane, diethyl ether, dichloromethane, and the like. Among these solvents, one kind or a mixture of two or more kinds of lower alcohols and hydrocarbon solvents is preferable.
이와 같이 제조되는 석곡 추출물은 고형분으로서 본 발명 조성물 전체 중량의 0.01∼10 중량%로 포함하는 것이 바람직하다. 0.01 중량% 미만에서는 모발 성장기 유도 촉진 효과가 만족스럽지 않고, 10 중량% 보다 높은 농도에서는 용량에 비하여 그 작용이 충분하게 나타나지는 않아 바람직하지 않다.The soybean extract prepared as described above is preferably included as a solid content in 0.01 to 10% by weight of the total weight of the composition of the present invention. If it is less than 0.01% by weight, the hair growth phase induction promoting effect is not satisfactory, and at a concentration higher than 10% by weight, the effect thereof is not sufficient compared to the dose, which is not preferable.
본 발명의 조성물에 석곡 추출물과 함께 포함될 수 있는 5α-리덕타제 활성 억제 성분은 인간의 모낭에서 5α-리덕타제의 작용을 억제함으로써 탈모 방지 효과를 나타내는 외용제의 배합성분으로, 안전성 면에서 문제가 없는 한 특별히 한정된 것은 아니며, 단독 또는 두 가지 성분 이상을 조합하여 배합할 수 있다. 이와 같은 5α-리덕타제 활성 억제 성분으로는, 예를 들어, 고삼 추출물, 의이인 추출물, 정향 추출물, 부평초 추출물, 자작나무 추출물, 오배자 추출물, 강활 추출물, 고본 추출물, 대황 추출물, 도인 추출물, 백강잠 추출물, 백급 추출물, 빈랑자 추출물, 소엽 추출물, 울금 추출물, 작약 추출물, 적작약 추출물, 조각자 추출물, 아선약 추출물, 회향 추출물, 원지 추출물, 형개 추출물, 견우자 추출물, 차전자 추출물, 소태나무 추출물 등과 같은 식물 유래 생약 성분을 사용할 수 있다. 이들 생약은 통상 대한약전 또는 생약규격집 등의 공정서에 수재된 것으로 시중에서 유통되는 일반적으로 입수할 수 있는 것들이다. 이들 생약의 추출물은, 통상의 용매 추출 방법에 의해 얻은 것으로 용매 선택에 있어 특별히 한정되지는 않는다.The 5α-reductase activity inhibitory ingredient which may be included with the grain extract in the composition of the present invention is a compounding ingredient of an external preparation that exhibits a hair loss prevention effect by inhibiting the action of 5α-reductase in human hair follicles, and has no problem in terms of safety. It is not specifically limited, It can mix | blend individually or in combination of 2 or more components. Such 5α-reductase activity inhibitory ingredients include, for example, ginseng extract, uiyiin extract, clove extract, Bupyeongcho extract, birch extract, gallja extract, active extract, honbon extract, rhubarb extract, ginko extract, baekjajam extract, Plant-derived herbal ingredients such as white extract, betel extract, leaflet extract, turmeric extract, peony extract, red peony extract, engraver extract, thyme extract, fennel extract, native extract, mold extract, cow extract, tea extract, bovine extract Can be used. These herbal medicines are generally available in the process of the Korean Pharmacopoeia or herbal medicine standard, and are generally available on the market. The extracts of these herbal medicines are obtained by a conventional solvent extraction method and are not particularly limited in selecting a solvent.
본 발명의 조성물에 있어서, 5α-리덕타제 활성 억제 성분의 함유량은 조성물 전체에 대하여 농축 고형물로서 0.001 내지 10.0 중량%인 것이 바람직하며, 0.01 내지 5.0 중량%인 것이 특히 바람직하다.In the composition of the present invention, the content of the 5α-reductase activity inhibiting component is preferably 0.001 to 10.0% by weight, particularly preferably 0.01 to 5.0% by weight, based on the total composition.
또한, 본 발명의 조성물에는, 석곡 추출물이나 5α-리덕타제 활성 억제 성분의 작용을 보강하고 탈모 환자가 사용하기에 적합하도록 부가적인 기능을 부여하기 위해 비듬 방지제, 각질 연화제, 청량제, 보습제 등의 보조 성분들을 첨가할 수 있으며, 이 경우 더욱 우수한 효과를 나타낸다.In addition, the composition of the present invention, to enhance the action of the grain extract or 5α-reductase activity inhibiting component and to impart additional functions suitable for use by alopecia patients, supplements such as anti-dandruff, keratin softeners, softening agents, moisturizing agents, etc. The components can be added, in which case a better effect is obtained.
이들 통상의 탈모방지, 모발 성장 촉진제에 배합되는 비듬 방지제, 각질 연화제, 청량제, 보습제 등의 보조 성분으로는 히노키티올, 고추틴크, 니코틴산벤질, 피록톤올아민, 살리실산, 엘-멘톨 등을 예로 들 수 있다. 이들 보조 성분은 주성분의 효과에 방해를 주지 않고 제형을 유지할 수 있는 범위에서 사용 농도에 대한 제한은 두지 않으나 인체 안전성이나 제형 안정성을 고려할 때, 히노키티올은 0.001∼0.1 중량%, 고추틴크는 0.001∼10 중량%, 니코틴산벤질은 0.001∼0.1 중량%, 피록톤올아민은 0.001∼1.0 중량%, 살리실산 및 엘-멘톨은 각각 0.01∼1.0 중량% 농도로 첨가되는 것이 바람직하다.Examples of auxiliary components, such as anti-dandruff agents, keratin softeners, coolants, and moisturizers, which are incorporated into these conventional hair loss prevention agents and hair growth promoters, include hinokithiol, capsicum tink, nicotinic acid benzyl, pyroxtonolamine, salicylic acid, and el-menthol. have. These auxiliary ingredients do not limit the concentration used in the range in which the dosage form can be maintained without disturbing the effect of the main ingredient, but in consideration of human safety or formulation stability, 0.001 to 0.1% by weight of hinochithiol and 0.001 to 0.1% of red pepper tink. 10% by weight, benzyl nicotinate is added in an amount of 0.001 to 0.1% by weight, pyrotonolamine in an amount of 0.001 to 1.0% by weight, salicylic acid and el-menthol in 0.01 to 1.0% by weight, respectively.
본 발명의 모발 성장 촉진제 조성물은 액상, 크림상, 페이스트상, 또는 고체상 등 두피에 적용시킬 수 있는 모든 제형으로 제조할 수 있고, 통상의 첨가제를 가하여 모발 성장 촉진을 위한 샴푸, 헤어컨디셔너, 헤어로션, 액상의 양모제 타입 등의 조성물로 제조될 수 있으며, 여기에는 이들 제형의 에어졸 타입도 포함된다.Hair growth promoter composition of the present invention can be prepared in any formulation that can be applied to the scalp, such as liquid, cream, paste, or solid phase, shampoo, hair conditioner, hair lotion for promoting hair growth by adding conventional additives It may be prepared in a composition such as a liquid wool type, and this also includes an aerosol type of these formulations.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명한다. 단, 이들 실시예는 본 발명의 예시일 뿐, 본 발명의 범위가 이들만으로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. However, these Examples are only illustrative of the present invention, and the scope of the present invention is not limited to these.
아래 효과시험예에서, 모발 성장기 유도 촉진 효과를 평가하는 동물시험 모델로서는 C57BL/6 마우스 모델을 사용하였는데, C57BL/6 마우스는 체모가 검정색이고, 자발적 탈모(spontaneous alopecia)가 일어나는 특징을 지니고 있으며, 또한 멜라노사이트(melanocyte)가 모낭에만 한정적으로 존재하고 멜라닌(melanin) 합성이 모발 성장 주기(hair growth cycle)와 잘 일치되어 피부색으로 모발의 성장 주기를 판정할 수 있는 장점을 가져 모발 성장기 유도 작용에 대한 연구에 널리 이용되는 것이다.In the effect test examples below, the C57BL / 6 mouse model was used as an animal test model for evaluating hair growth induction promoting effect. The C57BL / 6 mouse has black hair and has spontaneous alopecia. In addition, melanocytes (melanocytes) are present only in the hair follicles, and melanin synthesis matches well with the hair growth cycle, which has the advantage of determining the hair growth cycle in terms of skin color. It is widely used for research.
제조예: 석곡 추출물의 제조 방법Preparation Example: Preparation Method of Seokgok Extract
본 발명의 실시예에 사용된 석곡 추출물은 다음과 같이 제조하였다:Seokgok extract used in the embodiment of the present invention was prepared as follows:
먼저 석곡의 지상부를 세절하여 10호 체를 통과시킨 다음 대한약전품 에탄올을 약 10 배량 가하여 5 일간 실온에서 냉침하였다. 추출된 원액을 와트만 #2 여과지를 사용하여 여과하고, 여과된 추출물을 감압농축기를 이용하여 45 ℃에서 추출 용매를 완전히 증발시켜 건조된 추출물을 얻었다. 수득률은 약 1.9∼2.5 %였다.First, the ground portion of Seokgok was chopped and passed through a sieve No. 10, and about 10 times the amount of ethanol of Korean pharmaceuticals was added thereto, followed by cooling at room temperature for 5 days. The extracted stock solution was filtered using Whatman # 2 filter paper, and the filtered extract was evaporated completely at 45 ° C. using a vacuum condenser to obtain a dried extract. Yield was about 1.9-2.5%.
효과 시험예 1: 석곡 추출물의 모발 성장기 유도 촉진 작용 평가Effect Test Example 1 Evaluation of Hair Growth Induction Promoting Effect of Stone Extracts
모발 성장기 유도 촉진 효과 실험은 모발 성장기 유도 작용 평가에 널리 이용되고 있는 생후 42∼49 일된 마우스(C57BL/6, 수컷)를 사용하였다. Hair growth phase induction promoting effect experiment was used 42-49 days old mice (C57BL / 6, male) widely used for the evaluation of hair growth phase induction action.
먼저, 마우스 등 부위의 털을 전기면도기를 이용하여 제거하고 각 마우스의 무게를 재서 몸무게가 골고루 분산이 되도록 12 마리씩 나누었다. 하루 동안 적응 기간을 두고 다음 날부터 제모 부위에 대조약 및 석곡 추출물을 도포하였다. 이때 대조약으로는 40% 에탄올을, 시험약으로는 제조예에서 제조한 석곡 추출물의 농축 고형물을 40% 에탄올로 여러 가지 농도로 희석해서 사용하였다. 마우스 개체당 등 부위에 1 일 1 회, 100 ㎕씩을 28 일간 도포하여 성장기 유도 촉진 작용을 관찰하였으며, 그 결과를 화상분석기를 이용하여 털을 제거한 면적에 대하여 신생모가 자란 면적의 비율을 구하고 그 평균값으로 평가하였다. 아래 표 1은 석곡 추출물의 모발 성장기 유도 촉진 작용 평가 결과로서, 농도에 따른 효과를 보여준다.First, the hair on the back of the mouse was removed using an electric razor, and each mouse was weighed and divided into 12 pieces so that the weight was evenly distributed. After one day of adaptation, the control drug and the grain extract were applied to the hair removal site from the next day. At this time, 40% ethanol was used as a reference drug, and the concentrated solid of the Seokok extract prepared in Preparation Example was diluted to 40% ethanol at various concentrations. 100 µl each was applied to the back of the mouse once a day for 28 days to observe the growth-induction promoting effect. The results were obtained by using an image analyzer to determine the ratio of the area where the newborn hair was grown to the area from which hair was removed. Evaluated. Table 1 below shows the results of the hair growth phase induction promoting action of the Seokok extract, shows the effect according to the concentration.
위 표 1에 나타난 바와 같이, 석곡 추출물은 농도 의존적으로 매우 우수한 모발 성장기 유도 촉진 작용을 나타내었다. 0.01% 보다 낮은 농도에서는 모발 성장기 유도 촉진이 대조군 보다는 양호하였으나 만족할 만한 수준은 아니었으며, 10% 보다 높은 농도에서는 용량에 비하여 그 작용이 충분하게 나타나지는 않았다.As shown in Table 1, the Seokgok extract showed a very good hair growth induction promoting action in a concentration-dependent manner. At concentrations lower than 0.01%, hair growth phase induction was better than the control, but not satisfactory. At concentrations higher than 10%, the action was not sufficient.
효과 시험예 2: 석곡 추출물의 모낭세포 활성 증가 평가Effect Test Example 2 Evaluation of Increased Hair Follicle Activity of Seokgok Extracts
성형외과로부터 두피 수술 후의 사람 두피 조직을 얻어 이로부터 모낭조직을 분리하였다. 먼저, 두피 조직을 70% 에탄올에 1 분간 침적하여 멸균시키고 세포배양용 배지인 M199로 3 회 세척하였다. 입체 현미경 하에서 표피와 진피의 경계부를 수술용 메스로 절개하여 표피를 분리시키고, 진피에 박혀 있는 모낭을 핀셋을 이용 하여 1 개씩 뽑아내었다. 분리된 모낭을 10% 우태혈청(FBS, Fetal Bovine Serum)이 함유되어 있는 M199 배양액으로 옮기고 모유두가 들어있는 모낭의 아래 부분을 메스로 절단하였다. 미세한 핀셋을 이용하여 모유두를 분리하고 이를 20% FBS가 함유된 M199 배양액으로 옮겨 2 주간 배양하였다. 모유두 조직으로부터 세포가 자라나기 시작하면서 배양용기에 가득 차면 0.25% 트립신, 0.02% EDTA로 세포를 배양용기에서 분리한 후 계대 배양하여 세포를 계속 배양하였다.Human scalp tissue after scalp surgery was obtained from plastic surgery and hair follicle tissue was separated therefrom. First, the scalp tissue was sterilized by soaking in 70% ethanol for 1 minute and washed three times with M199, a cell culture medium. Under the stereo microscope, the epidermis and the dermis were cut with a surgical scalpel to separate the epidermis, and hair follicles embedded in the dermis were pulled out one by one using tweezers. The isolated hair follicles were transferred to M199 culture solution containing 10% fetal bovine serum (FBS), and the lower part of the hair follicles containing the dermal papilla was cut with a scalpel. The teat was separated using fine tweezers and transferred to M199 culture medium containing 20% FBS and incubated for 2 weeks. When cells grew from the dermal papilla tissue and filled with the culture vessel, the cells were separated from the culture vessel with 0.25% trypsin and 0.02% EDTA, followed by subculture.
2∼3 계대의 모유두 세포를 10% FBS가 들어 있는 M199 배양액으로 2×104/㎖ 농도로 희석한 후 이를 60 ㎜ 배양용기에 5 ㎖씩 넣어주고 37 ℃ 배양기에서 24 시간 배양하였다. 다음 날 FBS가 함유된 배양액을 제거하고 FBS가 들어 있지 않은 배양액 및 석곡 추출물이 함유된 배양액으로 교환하여 24 시간 배양한 후, 방사선으로 표지된 타이미딘(Thymidine)을 배양접시당 10 μCi씩 첨가해주고 24 시간을 더 배양하였다. 배양이 끝난 세포를 인산 완충용액으로 3 회 씻어주고 5% 트리클로로아세트산(trichloroacetic acid)으로 1 회 세척하였다. 세포를 0.1% 소디움도데실설페이트, 0.5N 수산화나트륨 용액으로 녹인 후 신틸레이션 칵테일(scintillation cocktail)에 섞어주고 방사선 동위원소의 양을 베타-카운터(β-counter)를 이용하여 측정하였다. 세포활성도는 대조군에 대하여 방사능 표지된 타이미딘을 세포내로 어느 정도 많이 업테이크(uptake)하였는지로 비교 평가하였다.2 ~ 3 passages of dermal papilla cells were diluted to a concentration of 2 × 10 4 / ㎖ with M199 culture medium containing 10% FBS, 5 ml each of the 60 mm culture vessel was incubated for 24 hours in a 37 ℃ incubator. The next day, the culture medium containing FBS was removed, the culture medium containing FBS and the culture medium containing the Seokgok extract were incubated for 24 hours, and then radiation-labeled thymidine was added 10 μCi per plate. And further incubated for 24 hours. The cultured cells were washed three times with phosphate buffer and washed once with 5% trichloroacetic acid. Cells were dissolved in 0.1% sodium dodecyl sulfate and 0.5 N sodium hydroxide solution, mixed in a scintillation cocktail, and the amount of radioisotope was measured using a beta-counter. Cell activity was evaluated by comparing how much uptake of radiolabeled thymidine into the cells.
이와 같은 타이미딘 업테이크(Thymidine uptake) 측정방법을 통해 석곡 추출물의 모낭세포 활성도를 측정한 결과, 비교적 낮은 농도(10-4∼10-6 %)에서 매우 우 수한 모낭세포 활성 작용을 나타내었다. 다음 표 2는 석곡추출물의 모낭세포 활성도 평가 결과로, 농도에 따른 효과를 보여준다.As a result of measuring the hair follicle activity of the Seokgok extract by the thymidine uptake measurement method, the hair follicle cell activity was excellent at relatively low concentration (10 -4 ~ 10 -6 %). . Table 2 shows the results of the hair follicle activity evaluation of the grain extract, the effect of the concentration.
이상의 결과에서 보듯이, 석곡 추출물은 직접적으로 모낭상피에 작용하여 모발 성장 촉진 효과를 나타내는 것으로 판단된다.As can be seen from the above results, the stone extract is directly acted on the hair follicle epithelium, it is judged to have a hair growth promoting effect.
실시예 1 내지 4 및 비교예 1 및 2Examples 1-4 and Comparative Examples 1 and 2
다음 표 3의 처방에 따라, 석곡 추출물을 포함하는 실시예 1 및 2의 조성물, 그리고 석곡 추출물에 더하여, 5α-리덕타제 활성 억제 성분으로 알려진 고삼 추출물이나 정향 추출물을 더욱 포함하는 실시예 3 및 4의 조성물, 그리고 석곡 추출물을 포함하지 않는 비교예 1 및 2의 조성물을 제조하였다.According to the formulation of Table 3, in addition to the compositions of Examples 1 and 2, including the Seokgok extract, and in addition to the Seokgok extract, Examples 3 and 4 further comprising a ginseng extract or clove extract known as a 5α-reductase activity inhibiting component The composition of Comparative Example 1 and 2, and did not include the grain extract was prepared.
효과 시험예 3: 동물실험에 의한 모발 성장 촉진 효과 평가Effect Test Example 3: Evaluation of hair growth promoting effect by animal experiment
위 표 3과 같은 조성비로 제조한 각각의 조성물을 가지고, 석곡 추출물의 모발 성장기 유도 작용 평가에서와 동일한 방법으로 모발 성장 촉진 효과 실험을 실시하였다. 본 조성물에 사용된 추출물은 제조예에 따른 농축 고형물을 사용하였다. 아래 표 4는 모발 성장기 유도 촉진 작용 평가 결과를 보여준다. With each of the compositions prepared in the composition ratio as shown in Table 3 above, the hair growth promoting effect experiment was carried out in the same manner as in the evaluation of the hair growth phase induced action of the Seokok extract. Extract used in the composition used a concentrated solid according to the preparation. Table 4 below shows the results of the hair growth phase induction promoting action evaluation.
위 표 4에서 보듯이, 5α-리덕타제 활성 억제 성분만을 함유하는 비교예 1 및 비교예 2에서도 모발 성장 촉진 작용이 나타났으나 만족할 만한 수준은 아니었다. 석곡 추출물 단독으로 함유한 실시예 1 및 실시예 2는 우수한 모발 성장 촉진 작용을 나타내었으며, 나아가 석곡 추출물과 함께 고삼 추출물 또는 정향 추출물을 동시에 함유하는 실시예 3 및 실시예 4에서는 각각의 유효성분을 단독으로 사용하였을 경우보다 더욱 우수한 모발 성장 촉진 작용을 나타내었다.As shown in Table 4 above, hair growth promoting action was also observed in Comparative Example 1 and Comparative Example 2 containing only the 5α-reductase activity inhibiting component, but was not satisfactory. Example 1 and Example 2 containing only the grains extract exhibited excellent hair growth promoting action, and furthermore, in Examples 3 and 4 simultaneously containing the ginseng extract or clove extract together with the grains extract, It showed more excellent hair growth promoting action than when used alone.
이와 같은 결과는 석곡 추출물의 모발 성장기 유도 촉진 작용과 함께 5α-리덕타제 활성 억제 작용이 같이 진행될 경우 모발 성장 촉진 작용에 대하여 우수한 시너지 효과를 나타냄을 의미한다.These results indicate that the synergistic effect on the hair growth promoting action when the effect of inhibiting 5α-reductase activity together with the hair growth phase induction promoting action of the Seokok extract.
이상의 실험 결과들로부터 알 수 있는 바와 같이, 석곡 추출물과 함께 고삼 추출물 또는 정향 추출물을 동시에 함유하는 실시예에서는 각각 탈모방지 또는 모발성장 촉진 작용과 관련 있는 모발 성장기 유도 촉진 작용, 5α-리덕타제 활성 억제 작용 등 각기 다른 메커니즘을 통하여 매우 우수한 모발 성장 촉진 효과를 나타내었으며, 어느 한 성분도 다른 유효성분의 작용에 영향을 주지 않고 그 작용을 나타내었다. 따라서, 석곡 추출물과 함께 5α-리덕타제 활성 억제 작용을 갖는 성분을 적절히 배합하여 사용할 경우, 여러가지 복잡한 메커니즘으로 얽혀있는 탈모 현상에 대하여 다양한 작용을 제공함으로써, 어느 한 성분에 의한 단독작용을 나타내는 것보다 훨씬 우수한 탈모방지 또는 모발성장 촉진 효과를 기대할 수 있을 것으 로 판단된다.As can be seen from the above experimental results, in Examples containing both ginseng extract and cloves extract together with the Seokgok extract, hair growth phase induction promoting action and 5α-reductase activity inhibition, respectively, which are related to hair loss prevention or hair growth promoting action, respectively. Through different mechanisms, such as action, showed very good hair growth promoting effect, neither component showed the effect without affecting the action of the other active ingredient. Therefore, when appropriately used in combination with the Seokok extract and components having the inhibitory action of 5α-reductase activity, it provides various effects on the hair loss phenomenon entangled by various complex mechanisms, rather than showing the sole action by any one component We anticipate a much better hair loss prevention or hair growth promotion effect.
계속해서, 본 발명에 따라, 석곡 추출물 및 5α-리덕타제 활성 억제 작용을 갖는 유효성분과 함께 보조 성분을 포함하는 조성물을 액상의 양모제로 제조하여 탈모증이 있는 사람을 대상으로 임상 시험을 실시하였다.Subsequently, according to the present invention, a composition comprising an auxiliary ingredient together with a grain extract and an active ingredient having a 5α-reductase activity inhibitory activity was prepared as a liquid wool agent, and clinical trials were conducted in persons with alopecia.
실시예 5Example 5
본 발명에 따른 석곡 추출물과 함께 고삼 추출물 및 기타 보조성분을 함유하는 조성물을 하기와 같은 처방으로 제조하였다.A composition containing a ginseng extract and other auxiliary ingredients together with the Seokok extract according to the present invention was prepared by the following prescription.
석곡 추출물 0.5 중량%;0.5% by weight stone extract;
고삼 추출물 0.5 중량%;0.5% by weight of ginseng extract;
히노키티올 0.05 중량%, 고추틴크 1.0 중량%, 니코틴산벤질 0.01 중량%, 피록톤올아민 0.1 중량%, 살리실산 0.1 중량%, 엘-멘톨 0.1 중량%;0.05% by weight of hinokithiol, 1.0% by weight of red pepper tin, 0.01% by weight of benzyl nicotinate, 0.1% by weight of pyrotonolamine, 0.1% by weight of salicylic acid, 0.1% by weight of L-menthol;
에탄올 40.0 중량%, 정제수 57.64 중량%; (총 100 중량%)Ethanol 40.0 wt%, purified water 57.64 wt%; (100 wt% total)
효과 시험예 4: 석곡 추출물과 함께 고삼 추출물 및 기타 보조성분을 함유한 조성물의 임상 평가Effect Test Example 4: Clinical Evaluation of a Composition Containing Ginseng Extract and Other Auxiliary Components with Seokgok Extract
위 실시예 5에서 제조한 조성물에 대하여, 사람을 대상으로 하는 임상시험에서 그 효과를 확인하고자 탈모증이 있는 대상자를 선정하여 시험하였다.For the composition prepared in Example 5, in order to confirm the effect in human clinical trials were selected and tested for alopecia subjects.
피험자로서 20∼50 세까지의 성인 남녀 중 남성형 탈모증이 있는 사람 또는 일일 평균 탈모수가 100 개 이상인 사람 15 명씩을 대상으로 하여, 탈모 부위에 1 일 2∼3 회 수 방울(약 2 ㎖)을 도포하는 방식으로 실시하였으며, 효과 확인의 정도에 따라 최소 2 개월에서 최대 4 개월까지 실시하였다. Thirty-five drops (approximately 2 ml) were applied to the hair loss site for 15 males and females with male or female alopecia or daily average hair loss of 100 or more. It was carried out in a manner that was carried out, depending on the degree of effect confirmed from a minimum of 2 months to a maximum of 4 months.
효과의 판정은 세발시 일일 평균 탈모량, 육안 판정 소견 및 자각 증상 개선 정도를 다음의 평가 척도에 따라 5 단계로 평가하고(표 5), 종합적으로 전반적인 개선도를 상기 평가 척도의 평균으로 하였다. 최종 판정은 종합적인 전반 개선도 3.0 점 이상을 유효하다고 하였으며 그 결과는 다음 표 6에 나타내었다.To determine the effect, the average daily hair loss at trituration, gross findings, and the degree of improvement of subjective symptoms were evaluated in five stages according to the following evaluation scale (Table 5), and overall overall improvement was taken as the average of the evaluation scale. The final verdict was that the overall improvement was 3.0 points or more, and the results are shown in Table 6 below.
위 표 6에서 보듯이, 본 발명에 따라 석곡 추출물과 함께 5α-리덕타제 활성억제 성분 및 기타 보조 성분을 함유한 실시예 5의 조성물은, 세발시 탈모량, 자각 증상 및 육안 판정 등에서 경도의 개선 내지 중등도 개선 이상의 효과를 나타내어 탈모방지 및 모발 성장 촉진 효과가 매우 우수함을 알 수 있다. 또한, 임상시험에서의 사용기간 동안 대상자 전원에게서 어떠한 부작용도 발견되지 않아 인체에도 안전한 조성물임을 알 수 있다.As shown in Table 6 above, the composition of Example 5 containing 5α-reductase activity inhibitory component and other auxiliary components together with the Seokgok extract according to the present invention, the improvement of hardness in the amount of hair loss during hair loss, subjective symptoms and visual determination It can be seen that the effect of more than moderate to moderate improvement is very excellent in preventing hair loss and promoting hair growth. In addition, no adverse effects were found in all subjects during the trial period, indicating that the composition is safe for humans.
이상의 결과를 종합하여 보면, 석곡 추출물은 동물실험 모델에서 모발 성장기 유도 촉진 효과 뿐 아니라 모낭세포에 대한 활성 작용도 우수하게 나타났다. 또한, 석곡 추출물과 함께 5α-리덕타제 활성 억제 성분을 조합하였을 경우, 단독으로 사용하였을 때에 비하여 동물을 이용한 실험 및 탈모 환자를 대상으로 한 임상 시험에서 매우 우수한 효과를 나타내었다. 따라서, 이들 2 종의 성분을 적절히 배합하여 사용할 경우, 여러가지 복잡한 메커니즘으로 얽혀있는 탈모 현상에 대하여 다양한 작용을 제공함으로써 어느 한 성분에 의한 단독작용을 나타내는 것보다 매우 우수한 탈모방지 및 모발성장 촉진 효과를 나타냄을 알 수 있다.Taken together, the Seokgok extract was found to have an excellent effect on hair follicle cells as well as promoting hair growth induction in an animal model. In addition, the combination of the 5α-reductase activity inhibitory component with the Seokkok extract showed a very good effect in experiments using animals and clinical trials in alopecia patients compared to when used alone. Therefore, when appropriately used in combination of these two components, by providing a variety of actions to the hair loss phenomenon entangled by various complex mechanisms, it is much better to prevent hair loss and promote hair growth than to exhibit a single action by any one component It can be seen that.
본 발명에 따라 모발 성장 촉진을 위한 유효성분으로서 모발의 성장기 유도 촉진 작용과 모낭세포 활성 작용이 우수한 석곡 추출물을 함유하는 모발성장 촉진제 조성물은 부작용이 거의 없고 우수한 모발 성장 촉진 및 탈모방지 효과를 나타낸다. 또한, 본 발명에 따른 조성물은 석곡 추출물과 함께 5α-리덕타제 활성 억제 작용이 있는 성분을 동시에 함유하였을 경우에도 매우 안전하며 더욱 우수한 탈모방지 및 모발 성장 촉진 효과가 있다.According to the present invention, a hair growth accelerator composition containing a grain extract having excellent hair growth induction promoting action and hair follicle cell activation action as an active ingredient for promoting hair growth has almost no side effects and exhibits excellent hair growth promoting and hair loss prevention effects. In addition, the composition according to the present invention is very safe even when it contains a component having a 5α-reductase activity inhibitory action at the same time with the Seokkok extract and has an excellent hair loss prevention and hair growth promoting effect.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020040057508A KR20060008662A (en) | 2004-07-23 | 2004-07-23 | Hair growth promoter composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020040057508A KR20060008662A (en) | 2004-07-23 | 2004-07-23 | Hair growth promoter composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20060008662A true KR20060008662A (en) | 2006-01-27 |
Family
ID=37119653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020040057508A Ceased KR20060008662A (en) | 2004-07-23 | 2004-07-23 | Hair growth promoter composition |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20060008662A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108042458A (en) * | 2018-01-10 | 2018-05-18 | 中国科学院昆明植物研究所 | Dendrobium meihua extract and its application in the preparation of cosmetics |
| CN110559394A (en) * | 2018-06-06 | 2019-12-13 | 捷通国际有限公司 | Composition containing dendrobium nobile and using method thereof |
| CN115335069A (en) * | 2020-07-20 | 2022-11-11 | 大峰Ls株式会社 | Composition for preventing alopecia and promoting hair growth containing extract of aerial parts of carrot |
| KR20230026758A (en) | 2021-08-18 | 2023-02-27 | 주식회사 현대바이오랜드 | Bacillus siamensis HDB8077 strain isolated from Dendrobium candidum flower and haircare cosmetic composition contained culture of Dendrobium candidum flower using thereof |
-
2004
- 2004-07-23 KR KR1020040057508A patent/KR20060008662A/en not_active Ceased
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108042458A (en) * | 2018-01-10 | 2018-05-18 | 中国科学院昆明植物研究所 | Dendrobium meihua extract and its application in the preparation of cosmetics |
| CN110559394A (en) * | 2018-06-06 | 2019-12-13 | 捷通国际有限公司 | Composition containing dendrobium nobile and using method thereof |
| CN115335069A (en) * | 2020-07-20 | 2022-11-11 | 大峰Ls株式会社 | Composition for preventing alopecia and promoting hair growth containing extract of aerial parts of carrot |
| KR20230026758A (en) | 2021-08-18 | 2023-02-27 | 주식회사 현대바이오랜드 | Bacillus siamensis HDB8077 strain isolated from Dendrobium candidum flower and haircare cosmetic composition contained culture of Dendrobium candidum flower using thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100839704B1 (en) | Hair growth and hair growth composition | |
| KR100846572B1 (en) | Anti-hair loss and hair growth promoting pharmaceutical composition containing coating extract | |
| KR101787531B1 (en) | Composition for preventing hair loss comprising extracts of crude drug complex | |
| KR20100116386A (en) | Composition for hair growth | |
| JP2003176213A (en) | Hair restorer | |
| KR101066797B1 (en) | Hair growth promoter composition | |
| KR101114307B1 (en) | Cosmetic composition having hair loss prevention and hair growth promoting effect | |
| KR100484236B1 (en) | Hair Growth Promoting Composition | |
| KR101965595B1 (en) | Composition for prevention of losing hair or promotion of growing hair | |
| KR20060095062A (en) | Hair growth promoter composition | |
| KR101359278B1 (en) | Composition comprising the extract of seaweeds for prevention of losing hair or promotion of growing hair | |
| JP2014185131A (en) | Hair growing agent and hair cosmetic for hair growth | |
| JP2014185130A (en) | Hair cosmetic for hair growth | |
| US9161900B2 (en) | Cosmetic composition for inhibiting hair loss and enhanced hair growth | |
| TW201517929A (en) | Method and composition for using blackberry extract for improving hair quality | |
| KR20060008662A (en) | Hair growth promoter composition | |
| CN100581532C (en) | Hair growth agent composition | |
| JPH1160450A (en) | Hair tonic | |
| KR100992414B1 (en) | Hair loss prevention or hair growth cosmetic composition containing ficus leaf extract | |
| KR101987422B1 (en) | Cosmetic composition for promoting hair growth and preventing hair loss comprising pumkin seed, phaseolus radiatus, juglans sinesis and urtica thunbergiana extract | |
| JP2002284648A (en) | Hair restorer composition | |
| KR100750473B1 (en) | Hair growth promoter composition | |
| KR20040092755A (en) | Hair growth promoting composition | |
| KR102852433B1 (en) | Composition For Preventing, Improving, Or Treating Hair Loss, Or For Promoting Hair Growth Containing Traditional Herbal-Derived Natural Extract Water And Extract | |
| KR101131685B1 (en) | Cosmetic compositions having sebosuppressive effect |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20040723 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20081230 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20040723 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20110119 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20110919 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20110119 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |